Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with<i>IDH1</i>Mutation

Abstract

Tumor enhancement on postcontrast MR imaging is a valuable prognostic factor for patients with anaplastic glioma and IDH1 mutation. Furthermore, the contrast-enhancement patterns could potentially be used to stratify the survival outcome of such patients.